ENDOSERUM® Product Information

ENDOSERUM®

Salmonella typhimurium antiserum, Equine origin
Re-17 Derived Mutagenically

Labeled to be diluted 1:1 with any isotonic solution. Administered intravenously and given slowly over not less than 30 minutes.

Dosage:

Horses with endotoxemia:
0.7 ml serum/lb body weight IV (diluted 1:1)

Foals with Failure of Passive Transfer (FPT):
7.0 ml serum/lb body weight IV (diluted 1:1)

Sizes Available:

250 ml bottle
500 ml bottle

FEATURES AND BENEFITS

1. Designed for the treatment of endotoxin-mediated diseases caused by E. coli and Salmonella typhimurium.
2. Reduces mortality associated with E. coli and Salmonella in horses.
3. Contains total IgG levels greater than 3000 mg/dl for correction of FPT in foals.
4. Refrigerated, not frozen.
5. “Re-17 Derived Mutagenically” on label denotes cross-protection.
6. 36-month shelf life.